Peripheral Artery Disease (PAD) Market By Treatment Type (Pharmacological, Surgical, Endovascular); By Diagnostic Modality (ABI Testing, Ultrasound, CTA, MRA); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Artery Disease (PAD) Market is expected to grow at a CAGR of 6.3% from 2024 to 2030, valued at USD 6.5 billion in 2024 , and projected to reach USD 10.2 billion by 2030 , confirms Strategic Market Research.

 

PAD is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs, commonly affecting the legs. The strategic significance of the PAD market is on the rise due to the growing aging population, increasing prevalence of risk factors like diabetes and hypertension, and advancements in minimally invasive treatment methods.

 

The global burden of PAD is escalating due to lifestyle changes, urbanization, and the growing incidence of risk factors. New technologies and a shift towards early detection and personalized treatment are driving the growth. The market is witnessing innovations in diagnostic and therapeutic technologies, with an emphasis on non-invasive and less painful treatments.

 

In terms of stakeholders, key players in this market include medical device manufacturers, healthcare providers, government agencies , and research institutions . Governments are increasing their focus on preventive healthcare and chronic disease management, further pushing market growth.

 

Key Drivers:

• Aging population, increasing incidence of risk factors

• Advancements in diagnostic tools and treatment technologies

• Increased focus on early intervention and personalized medicine.

In conclusion, PAD is no longer considered just a vascular issue, but a serious concern that requires a multi-faceted treatment approach across the healthcare ecosystem.

 

Market Segmentation And Forecast Scope

The Peripheral Artery Disease (PAD) market is segmented across several dimensions, each focusing on critical factors that affect diagnosis, treatment, and patient management. The segmentation includes by type of treatment, diagnostic modalities, end users, and geography . Below is a breakdown of the key segments:

By Treatment Type

• Pharmacological Treatment:
  Medications like antiplatelet agents, statins, and vasodilators play a significant role in symptom management and preventing disease progression.
  Segment share in 2024 : 32%
  Pharmacological treatments continue to lead, driven by the large patient population requiring long-term management.

• Surgical and Interventional Procedures:
  Includes angioplasty, stent placement, and bypass surgeries.
  Segment share in 2024 : 40%
  This segment is growing due to the increasing adoption of minimally invasive surgeries like endovenous laser therapy (EVLT).

• Endovascular Treatments:
  The rise of minimally invasive procedures such as balloon angioplasty and laser atherectomy is driving the endovascular market.
  Segment share in 2024 : 28%
  Endovascular procedures are expanding rapidly due to their reduced recovery times and better patient outcomes.

 

By Diagnostic Modality

• Ankle-Brachial Index (ABI) : Still considered the most effective non-invasive test for diagnosing PAD.

• Ultrasound : Non-invasive imaging technology widely used in diagnostics.

• Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) : Emerging modalities for more precise imaging of the arterial blockages, increasing their adoption among clinicians.

The demand for non-invasive diagnostic methods, such as ABI and ultrasound, is on the rise due to their affordability and high accuracy.

 

By End User

• Hospitals and Clinics :These facilities remain the largest end-user, providing a broad range of treatments from diagnostics to surgical procedures.

• Ambulatory Surgical Centers (ASCs) : With a rising preference for outpatient care, ASCs are gaining traction, especially for procedures like angioplasty.

• Diagnostic Imaging Centers : Increasing demand for PAD diagnosis in standalone diagnostic centers , particularly for non-invasive tests.

 

By Region:

• North America : Largest market share due to advanced healthcare infrastructure, high prevalence of risk factors (e.g., diabetes), and reimbursement policies.

• Europe : Strong growth driven by public health initiatives and well-established medical device standards.

• Asia Pacific : Fastest-growing region due to rising healthcare access, aging populations, and increasing awareness.

• Latin America and Middle East & Africa (LAMEA) : Slowly catching up with increasing investments in healthcare infrastructure and PAD awareness.

Notably, North America will continue to lead in terms of both market size and treatment advancements, but Asia-Pacific is projected to be the fastest-growing region during the forecast period due to its demographic trends and growing healthcare infrastructure.

 

Market Trends And Innovation Landscape

The Peripheral Artery Disease (PAD) market is undergoing significant transformation, driven by innovations across diagnostic tools, treatment modalities, and patient management technologies . Several key trends and innovations are shaping the market, making it more accessible, effective, and patient-centric.

Advancements in Minimally Invasive Treatments

Minimally invasive procedures are gaining ground due to their lower complication rates, quicker recovery times, and improved patient outcomes. Innovations in endovascular treatments , such as drug-coated balloons (DCBs) and stent technologies , have significantly improved the effectiveness of PAD interventions. These technologies not only open up blocked arteries but also reduce the likelihood of re-blockage, thus minimizing the need for repeat procedures.

The shift toward more refined drug-eluting stents and novel stent designs is enhancing long-term patient outcomes and reducing the rate of restenosis.

 

AI and Machine Learning in Diagnostics

Artificial Intelligence (AI) is being increasingly integrated into diagnostic imaging for PAD, helping to detect subtle signs of arterial blockage that may be missed by traditional methods. AI-powered ultrasound devices are being developed to offer real-time data analysis, thus reducing human error and improving diagnostic accuracy. Moreover, machine learning algorithms are being utilized to predict disease progression, assess the risk of cardiovascular events, and help clinicians personalize treatment plans for PAD patients.

AI’s potential in early detection and predictive analytics is accelerating the move toward precision medicine, which allows for earlier interventions and customized therapies.

 

Point-of-Care Diagnostics

Another significant trend is the development of portable and handheld diagnostic devices . Devices like portable ABI devices and pocket-sized ultrasounds are transforming the way PAD is diagnosed, especially in rural and underserved areas. These point-of-care diagnostics not only improve patient access to care but also streamline workflow in emergency departments and primary care settings. This trend is expected to drive rapid adoption in regions with less advanced healthcare infrastructure.

These portable devices are becoming indispensable in diagnosing PAD in resource-limited settings, improving early detection and reducing healthcare costs.

 

Focus on Preventive Care and Early Detection

There is growing emphasis on preventive care , with increasing awareness about PAD's link to cardiovascular diseases, especially among people with diabetes, hypertension, and obesity. Public health campaigns and educational efforts are encouraging early detection and screening, particularly for high-risk groups. The global rise in diabetes prevalence is a major driver of PAD diagnosis, as individuals with diabetes are more likely to develop arterial blockages.

With greater awareness and adoption of early screening, PAD diagnosis is expected to improve significantly, helping to mitigate severe complications and reduce long-term healthcare burdens.

 

Telemedicine and Remote Monitoring

The integration of telemedicine and remote monitoring into PAD management is gaining momentum. Remote monitoring devices can track blood flow, pain levels, and overall limb health, allowing physicians to monitor their patients' progress remotely. This is especially important for patients in rural areas who have limited access to specialized PAD care. These technologies are helping reduce unnecessary hospital visits and enabling continuous management of the disease.

Remote monitoring not only improves patient outcomes but also enhances efficiency in managing chronic diseases, potentially lowering healthcare costs over time.

As we look ahead, the landscape of PAD management is clearly shifting towards personalized, minimally invasive treatments supported by advanced diagnostic technologies. The integration of AI, portable diagnostics, and telehealth will likely continue to reshape patient care, making it more efficient and accessible.

 

Competitive Intelligence And Benchmarking

The Peripheral Artery Disease (PAD) market is highly competitive, with a mix of established medical device companies and emerging innovators driving technological advancements. The leading players in the market are focusing on product innovation, strategic partnerships, and expanding their presence across regions to capture market share. Below are some of the key players and their competitive strategies:

Medtronic

Medtronic is a global leader in PAD treatment, known for its advanced endovascular technologies, including drug-eluting stents, angioplasty balloons, and the Vena Cava Filter . The company’s continuous focus on innovation, such as the HawkOne directional atherectomy system and IN.PACT Admiral drug-coated balloon, has made it a dominant force in the PAD market. Medtronic’s strategy revolves around providing comprehensive treatment solutions, including diagnostic tools, stents, and therapies that allow for a more personalized approach to PAD management.

Medtronic’s broad portfolio and global presence enable it to cater to diverse patient needs, while its focus on innovative technologies gives it a competitive edge in both mature and emerging markets.

 

Boston Scientific

Boston Scientific is another key player, with its Eluvia drug-eluting stent leading the charge in PAD treatment. The company is focused on developing minimally invasive technologies that offer long-term outcomes and lower complication rates. In addition to endovascular solutions, Boston Scientific also invests heavily in AI and robotics for enhanced treatment precision, providing significant advancements in PAD management. The company's robust research and development (R&D) pipeline ensures continuous product innovation.

Boston Scientific’s strategic approach includes partnerships with healthcare providers and investment in expanding its portfolio in response to market demand for more effective PAD therapies.

 

Abbott Laboratories

Abbott Laboratories is recognized for its balloon angioplasty and stent technologies , along with diagnostic tools for PAD. Abbott’s Diamondback 360 orbital atherectomy system is one of its key products, offering enhanced treatment for peripheral vascular disease. Abbott’s strategy focuses on leveraging advanced imaging systems and next-generation stenting technologies, ensuring its competitive position in the growing PAD market.

Abbott’s focus on cardiovascular innovation and minimally invasive procedures continues to make it a key player, with strong growth expected in regions with expanding healthcare access.

 

Cook Medical

Cook Medical is renowned for its innovative medical devices used in the treatment of PAD, particularly catheters , stents , and balloon angioplasty products. The company continues to focus on enhancing the safety and effectiveness of its vascular devices. Cook Medical’s products are designed to provide patients with both short-term relief and long-term solutions for PAD.

Cook Medical’s reputation for high-quality, reliable products positions it well in the market, particularly in the mid- to low-cost device categories.

 

Cardinal Health

While Cardinal Health is more known for its medical supplies and logistics, its role in the PAD market is growing due to its expanding portfolio of diagnostic imaging systems and surgical tools. The company is making strategic investments in providing hospitals and diagnostic centers with cost-effective, high-quality equipment for PAD diagnosis and treatment.

Cardinal Health’s focus on providing affordable healthcare solutions in emerging markets offers growth opportunities in regions with rising healthcare demand.

 

Teleflex

Teleflex specializes in catheter-based devices and is expanding its PAD product offerings. Known for its Pediatrics and Respiratory Care divisions, the company has leveraged its existing technologies and applied them to PAD treatment. Teleflex’s strategy includes focusing on expanding its portfolio through acquisitions and partnerships with specialized hospitals and healthcare providers.

Teleflex’s ability to integrate its diverse product lines and technologies into PAD treatment makes it a competitive force, particularly in the catheter-based treatment market.

 

Key Trends in Competitive Landscape:

• Product Innovation – Companies are focused on improving the safety, effectiveness, and cost-efficiency of PAD treatments through innovations in stenting, drug-coated balloons, and minimally invasive procedures.

• Strategic Partnerships – Collaborations between device manufacturers, healthcare providers, and academic institutions are becoming more common to enhance research, product development, and market access.

• Emerging Markets Focus – With an increasing number of PAD cases in emerging markets like Asia-Pacific, companies are focusing on expanding their footprint in these high-growth regions through affordable treatment options and robust distribution networks.

The competition in the PAD market is intensifying, with leading players continuously refining their products to meet evolving patient and healthcare provider demands. The emphasis on early diagnosis, minimally invasive treatments, and precision medicine is expected to be key to future success.

 

Regional Landscape And Adoption Outlook

The adoption and growth of treatments for Peripheral Artery Disease (PAD) vary significantly across regions, influenced by healthcare infrastructure, economic conditions, regulatory environments, and the prevalence of risk factors like diabetes and hypertension. Here’s a breakdown of the regional dynamics:

North America

North America remains the largest and most mature market for PAD, primarily driven by the United States and Canada . This region has the highest PAD prevalence, largely due to the aging population and high rates of chronic conditions such as diabetes, hypertension, and smoking.

Key Factors Driving Growth :

• Advanced healthcare infrastructure : North America boasts state-of-the-art diagnostic and treatment technologies.

• Regulatory support : Reimbursement policies and government health programs, particularly Medicare and Medicaid, help to facilitate treatment access.

• Rising awareness : Health campaigns and increasing recognition of PAD as a serious vascular condition are prompting earlier diagnosis and intervention.

• Innovations : The U.S. is home to many leading PAD treatment companies, such as Medtronic and Boston Scientific, and continues to lead in innovation and adoption of minimally invasive treatments like drug-coated balloons and stents.

Growth Outlook : The market will maintain strong growth, driven by technological advancements in diagnostics and the rising adoption of minimally invasive procedures.

 

Europe

Europe follows closely behind North America, with regions like Germany , France , and the UK leading the way in PAD diagnosis and treatment. The growing awareness of PAD as a major cardiovascular risk factor is contributing to higher diagnosis rates.

Key Factors Driving Growth :

• Universal healthcare : Most European countries have well-established healthcare systems that support the diagnosis and treatment of PAD.

• Government health initiatives : Countries like the UK and Germany have public health campaigns targeting PAD awareness and prevention.

• Regulatory framework : The European Medicines Agency (EMA) plays a crucial role in driving the adoption of innovative PAD treatments.

Growth Outlook : Europe will see continued growth, driven by both high-value markets (like Germany and the UK) and emerging markets in Eastern Europe. Additionally, technological innovation, such as AI-based diagnostic systems and minimally invasive treatment methods, is expected to drive market expansion.

 

Asia Pacific

Asia-Pacific is the fastest-growing region in the PAD market, largely due to the rapid urbanization, aging populations, and growing prevalence of risk factors like diabetes and high cholesterol. Countries such as China , India , and Japan are seeing an increase in PAD cases, prompting significant investments in healthcare infrastructure.

Key Factors Driving Growth :

• Increasing healthcare access : Healthcare systems in countries like India and China are expanding, and government initiatives are improving access to treatment.

• Rising risk factors : Urbanization and lifestyle changes, including poor diet and lack of exercise, are contributing to higher rates of PAD in the region.

• Healthcare investments : There’s a significant push from both private and public sectors to upgrade healthcare infrastructure and provide innovative PAD treatments.

Growth Outlook : The market in Asia-Pacific is expected to continue its rapid expansion, fueled by rising healthcare access, increased government spending on healthcare, and a rising middle-class population demanding better healthcare services. Emerging countries will contribute significantly to the global growth of PAD treatments.

 

Latin America

Latin America is an emerging market for PAD, with Brazil , Mexico , and Argentina leading the charge in diagnostics and treatments. While PAD prevalence is lower than in North America and Europe, the region faces challenges like limited healthcare access in rural areas.

Key Factors Driving Growth :

• Urbanization : As urban populations increase, lifestyle diseases like PAD are becoming more prevalent.

• Public healthcare investments : Governments in Brazil and Mexico are investing in healthcare infrastructure, which is improving access to PAD treatments.

• Growing awareness : Increased focus on non-communicable diseases (NCDs) is driving PAD awareness and earlier diagnosis.

Growth Outlook : PAD treatment adoption is expected to rise steadily in Latin America, especially as governments invest in healthcare systems and patients demand advanced, minimally invasive treatments.

 

Middle East & Africa (MEA)

The Middle East and Africa (MEA) region remains underpenetrated but shows promise for growth, especially in GCC countries like Saudi Arabia and the UAE , where healthcare infrastructure is rapidly improving. South Africa is also a key market in Africa for PAD treatments.

Key Factors Driving Growth :

• Healthcare infrastructure development : Significant investments are being made in modernizing healthcare facilities in the Middle East.

• Rising healthcare needs : Growing urban populations and increasing rates of diabetes and hypertension are leading to a higher demand for PAD treatments.

• Government support : Government-funded healthcare programs in GCC countries are making PAD treatments more accessible.

Growth Outlook : The market will expand in LAMEA, driven by improvements in healthcare infrastructure, particularly in urban areas. However, challenges like limited access to care in rural regions and economic disparities may slow down the pace of growth in some African countries.

 

Key Regional Dynamics:

• North America and Europe will remain the leaders in PAD treatment and diagnostic technology innovation, with a focus on high-value treatments and expanding access to care.

• Asia Pacific will continue to experience rapid growth, driven by increasing healthcare access, rising disease burden, and demographic shifts.

• Latin America and LAMEA will see steady progress, with governments investing in infrastructure and increasing public health initiatives to tackle PAD.

 

In conclusion, the global PAD market is experiencing a dynamic shift, with emerging regions playing an increasingly significant role in its growth. Technological advancements, healthcare infrastructure improvements, and a greater focus on early diagnosis and treatment will continue to drive market expansion in the coming years.

 

End-User Dynamics And Use Case

The adoption of Peripheral Artery Disease (PAD) treatments and diagnostics varies across different end users. Each type of provider has specific needs and challenges when managing PAD patients. From specialized hospitals to outpatient diagnostic centers , the approach to PAD care differs based on the complexity of the cases, the available infrastructure, and the patient's needs.

Children’s Hospitals

While PAD is less common in children, certain pediatric patients, particularly those with congenital vascular conditions, may require specialized care. Children’s hospitals are increasingly investing in advanced diagnostic equipment to identify vascular abnormalities early. The adoption of pediatric -specific vascular imaging tools is critical, ensuring that even rare vascular conditions are diagnosed and treated effectively.

• Key Needs : High-resolution imaging, specialized vascular interventions, child-friendly environments for procedures.

• Challenges : Pediatric -specific vascular expertise is often limited.

 

General Hospitals

General hospitals handle the majority of PAD cases, especially in adult populations. These hospitals often provide both diagnostic and treatment services, from screening for PAD to performing minimally invasive procedures like angioplasty and stenting . Many hospitals now have dedicated vascular surgery departments to handle more complex PAD cases.

• Key Needs : Comprehensive diagnostic capabilities (ultrasound, ABI testing), high-quality endovascular treatment options, post-procedure monitoring.

• Challenges : Balancing PAD treatment with other vascular diseases, ensuring patient access to specialized care.

 

Diagnostic Imaging Centers

Diagnostic imaging centers are seeing increasing demand for PAD diagnosis, especially for non-invasive procedures like ABI testing and ultrasound imaging . These centers play a vital role in early detection and often collaborate with hospitals and clinics to provide diagnostic support. The rise of point-of-care diagnostic devices, such as portable ultrasound machines , is also enabling quicker diagnoses.

• Key Needs : Non-invasive diagnostic tools, fast turnaround times, and patient-friendly diagnostic procedures.

• Challenges : Managing patient flow, ensuring access to advanced imaging technologies.

 

Ambulatory Surgical Centers (ASCs)

Ambulatory surgical centers (ASCs) are playing a growing role in PAD treatment, particularly for less invasive procedures such as balloon angioplasty or stent placement . With the rise of outpatient care, ASCs offer a cost-effective and efficient option for treating PAD, especially in the stable stages of the disease. The trend towards same-day discharge after minimally invasive procedures is increasing, as is the use of local anesthesia in place of general sedation.

• Key Needs : Advanced endovascular treatment options, cost-effective solutions, quick recovery procedures.

• Challenges : Keeping up with growing demand for vascular interventions, managing post-procedure complications.

 

Use Case:

A community hospital in Texas faced a rise in PAD diagnoses among its elderly population. Traditionally, PAD diagnosis involved long waits for angiography, but the hospital adopted point-of-care ultrasound devices , allowing clinicians to quickly diagnose arterial blockages at the patient's bedside. By integrating this technology, the hospital reduced diagnostic times from several weeks to a matter of days, which improved patient outcomes by enabling earlier interventions.

In addition, the hospital implemented an AI-powered decision support tool for assessing PAD severity based on ultrasound images, helping clinicians make more accurate treatment decisions. The implementation of these tools not only enhanced operational efficiency but also increased patient satisfaction as they were able to receive faster and more personalized care.

Outcome : The community hospital saw a 25% increase in early-stage PAD diagnoses and a 30% reduction in hospital readmissions . Patient satisfaction improved due to shorter waiting times and quicker treatments.

End-user needs vary significantly in the PAD market, but all share a common requirement: efficiency in diagnosis and treatment. Hospitals and imaging centers need rapid, non-invasive tools that deliver precise results, while ASCs focus on cost-effective, outpatient solutions. As the demand for PAD treatments grows, these facilities will need to adapt to meet patient needs while managing the increasing complexity of care.

 

Recent Developments + Opportunities & Restraints

Recent Developments (Last 2 Years)

• Medtronic’s FDA Approval of the IN.PACT ™ AV Balloon for PAD (2024):
  Medtronic received FDA approval for its IN.PACT ™ AV drug-coated balloon specifically for use in treating PAD in patients with arteriovenous fistula (AVF) , which is commonly associated with dialysis patients. This approval is a significant milestone, broadening the indications for the use of this technology in PAD management.

• Boston Scientific’s Acquisition of EndoChoice Technologies (2023):
  Boston Scientific announced the acquisition of EndoChoice Technologies , expanding its portfolio to include advanced diagnostic tools for vascular diseases , including PAD. This acquisition aligns with the company’s focus on enhancing its imaging and diagnostic capabilities in PAD management.

• Abbott Launches Supera ™ Stent with Enhanced Durability (2023):
  Abbott introduced the Supera ™ stent , designed to provide superior long-term patency and flexibility, addressing the growing demand for more durable vascular interventions in PAD patients. The stent’s design has been shown to improve outcomes in more complex vascular anatomies.

• FDA Clearance for Philips’ AI-Powered PAD Diagnostic System (2024):
  Philips Healthcare received FDA clearance for its AI-based PAD diagnostic system , which uses advanced imaging algorithms to detect and predict arterial blockages. This AI system will help clinicians identify early-stage PAD with greater accuracy, paving the way for more personalized treatments.

• Teleflex’s Launch of a New Vascular Access Device (2023):
  Teleflex launched a new vascular access device designed to improve patient comfort during PAD treatments. The device, which is minimally invasive, provides better access to peripheral arteries, reducing complications and facilitating faster treatment options for PAD patients.

 

Opportunities

• Growth in Emerging Markets:
  There is significant potential for PAD market expansion in emerging economies like India, China, and Brazil. These regions are experiencing rapid urbanization, an aging population, and rising healthcare access. As PAD prevalence increases with lifestyle changes, the demand for both diagnostic and therapeutic PAD solutions will rise.
  In these markets, a focus on affordable, portable diagnostic tools and cost-effective treatment options is crucial to driving market adoption.

• AI and Machine Learning for Early Diagnosis:
  AI-based diagnostic systems are poised to revolutionize PAD management by enabling earlier detection and better treatment planning. AI algorithms integrated with imaging systems like ultrasound and angiography will help clinicians identify even subtle arterial blockages, allowing for more timely interventions.
  The ability of AI to analyze large datasets for early-stage PAD detection is a major opportunity for reducing the long-term impacts of the disease.

• Minimally Invasive Treatment Options:
  The trend toward minimally invasive treatments , including drug-coated balloons and peripheral stents , presents significant growth opportunities. These procedures offer shorter recovery times and fewer complications compared to traditional surgeries. As technologies advance, peripheral artery bypass and balloon angioplasty techniques will continue to dominate PAD treatment.
  For healthcare providers, these minimally invasive treatments will lead to better patient outcomes and cost savings, further driving their adoption.

• Telehealth and Remote Monitoring:
  With the rise of telemedicine and remote monitoring technologies , PAD patients can now be monitored more effectively from home, reducing hospital visits and improving ongoing management of the disease. Innovations in wearable devices that track vascular health and ABI measurements will continue to grow, making PAD care more accessible and patient-friendly.
  The integration of remote monitoring into PAD treatment will improve patient compliance and reduce healthcare burdens, particularly in rural or underserved areas.

 

Restraints

• High Equipment and Procedure Costs:
  Despite advancements, high costs associated with both PAD diagnostic equipment and surgical procedures remain a significant barrier, especially in price-sensitive regions . High-end procedures such as endovascular stenting and angioplasty can be financially burdensome for both patients and healthcare providers.
  The need for cost-effective diagnostic tools and affordable treatment options remains a key challenge, particularly in emerging markets where healthcare budgets are tighter.

• Skilled Workforce Shortage:
  The effective treatment of PAD, especially through minimally invasive procedures , requires skilled vascular surgeons, interventional radiologists, and well-trained medical staff. The shortage of trained professionals in some regions, particularly in rural areas, poses a challenge to widespread treatment access.
  Improving training programs and increasing the number of specialists in PAD management will be critical to ensuring that all patients have access to optimal care.

While the PAD market continues to experience growth due to innovation in treatments, diagnostics, and technological advancements, certain barriers remain. Addressing these challenges by focusing on cost-effective solutions and expanding healthcare infrastructure in emerging markets will be key to sustaining market momentum.

 

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 6.5 Billion
Revenue Forecast in 2030	USD 10.2 Billion
Overall Growth Rate (CAGR)	6.3% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Treatment Type, By Diagnostic Modality, By End User, By Region
By Treatment Type	Pharmacological, Surgical, Endovascular
By Diagnostic Modality	ABI Testing, Ultrasound, CTA, MRA
By End User	Hospitals, Diagnostic Imaging Centers, ASCs, General Hospitals
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Market Drivers	Aging Population, Diabetes Prevalence, Innovation in Minimally Invasive Treatments
Customization Option	Available upon request